论文部分内容阅读
目的分析研究依达拉奉注射液对急性脑出血的临床疗效。方法 92例急性脑出血患者作为此次的研究对象,将其按入院时间分为观察组与对照组,每组46例。对照组患者给予常规的内科治疗,观察组患者则在此基础上增加依达拉奉注射液进行治疗。对比观察两组患者的总有效率与治疗满意度。结果观察组患者的总有效率为97.83%,对照组患者的总有效率为84.78%,观察组总有效率高于对照组,差异具有统计学意义(P<0.05)。观察组患者的治疗满意度为97.83%,对照组患者的治疗满意度为82.61%,观察组患者的治疗满意度高于对照组,差异具有统计学意义(P<0.05)。结论给予急性脑出血患者加用依达拉奉注射液进行治疗,能够显著提高治疗的总有效率,治疗满意度评价高,减少了医患纠纷,提高了依从性,值得临床推广应用。
Objective To study the clinical effect of edaravone injection on acute cerebral hemorrhage. Methods A total of 92 patients with acute cerebral hemorrhage were included in this study. They were divided into observation group and control group according to the time of admission, with 46 cases in each group. Patients in the control group were given conventional medical treatment, while patients in the observation group were treated with edaravone injection on the basis of this. The total effective rate and treatment satisfaction of two groups were compared. Results The total effective rate of the observation group was 97.83%, while the total effective rate of the control group was 84.78%. The total effective rate of the observation group was higher than that of the control group (P <0.05). The treatment satisfaction of the observation group was 97.83%, that of the control group was 82.61%, and that of the observation group was higher than that of the control group (P <0.05). Conclusion The addition of edaravone in patients with acute intracerebral hemorrhage can significantly improve the total effective rate of treatment, evaluate the satisfaction of treatment, reduce the disputes between doctors and patients and improve the compliance, which is worthy of clinical application.